enGene Holdings Inc.

NASDAQ:ENGN

Biotechnology

Healthcare
$1.72 -1.15%

-$0.02 today

Market cap
$115.27M
Beta
-0.29
P/E (TTM)
-1.8
EPS (TTM)
-$0.95
52W Low $1.40High $12.25

Volume 1.64M

Average 1.58M

Price history

enGene Holdings Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-75.00%

Period high

$12.17

Period low

$1.44

Latest

$1.72

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
4Nov 13, 2026Nov 13, 2026
3Nov 13, 2026Nov 13, 2026
SC 13GNov 13, 2026Nov 13, 2026
8-KNov 12, 2026Nov 12, 2026
4Sep 24, 2026Sep 24, 2026
8-KSep 8, 2026Sep 8, 2026
10-QSep 8, 2026Sep 8, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13G/AAug 13, 2026Aug 13, 2026
SC 13G/AAug 12, 2026Aug 12, 2026
8-KAug 11, 2026Aug 11, 2026
3Jul 22, 2026Jul 22, 2026
3Jul 22, 2026Jul 22, 2026

Competitors

Who does enGene Holdings Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about ENGN's filings, answered from its disclosures.

What is the latest ENGN filing?

The latest filing shown is 4 dated Nov 13, 2026.

How many recent filings does ENGN have?

Intrinsic Alpha currently shows 20 recent filings for ENGN.